Invesco Retires $1.5B of MassMutual Preferred With New $1.5B Term Loan
IVZ sits 36% above its 52-week low of $20.67 on elevated volume (1.9× avg).
Summary
Invesco repurchased $1.5 billion of MassMutual's 5.9% Series A preferred at a 12.5% premium, funded with a new $1.5 billion five-year unsecured term loan carrying a 3.25x leverage covenant.
Key Events · Financing and Capital Events · IVZ
-
Preferred Buyback From MassMutual
Invesco repurchased 1,500,000 Series A Preference Shares at $1,125.00 per share, a 12.5% premium to the $1,000 liquidation preference, for $1.5 billion in aggregate.
-
New $1.5B Term Loan Funds Deal
An unsecured five-year term loan was borrowed in full on October 26, 2026, priced at Term SOFR plus 1.350% at current ratings, maturing October 26, 2031.
-
Leverage and Coverage Covenants
The credit agreement requires Debt/EBITDA of no more than 3.25:1.00 and interest coverage of at least 4.00:1.00, with a temporary step-up to 3.75:1.00 after a qualifying acquisition above $500 million.
-
Amortization Starts in Year Three
Principal payments of 2.5% per quarter begin on the third anniversary, with the balance due at maturity; an accordion allows expansion to $2.0 billion.
Analysis · IVZ · Finance
Invesco is buying back $1.5 billion of its 5.9% Series A preferred from MassMutual at a 12.5% premium to liquidation preference, funding the purchase entirely with a new $1.5 billion five-year unsecured term loan. The trade swaps expensive perpetual preferred dividends for term-loan interest, which should lower the annual cost of capital, but it also converts a perpetual equity-like instrument into funded debt with real covenants — a 3.25x Debt/EBITDA ceiling and 4.00x interest coverage — and pushes the first principal payment out to the third anniversary. MassMutual stays a large holder, keeping $1 billion of preferred and roughly 18.5% of the common, and the shareholder agreement was amended so its governance rights survive at the lower $1 billion preferred level. The main risk is leverage: the company now carries a $1.5 billion amortizing obligation maturing October 26, 2031, and the covenant package constrains future borrowing and asset sales.
How filings like this one have moved
In the 30 days to Oct 31, 2026, 40% of the 995 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IVZ was trading at $28.20 on NYSE in the Finance sector, with a market capitalization of approximately $12.6B. The 52-week trading range was $20.67 to $33.66. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.